Drug intelligence / Profile preview

Yixiao Decoction

Development stage: Preclinical
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Administration: Oral

Overview

Yixiao Decoction is a traditional Chinese medicine (TCM) herbal preparation currently under investigation for the treatment of type 2 diabetes complicated with left ventricular diastolic dysfunction. As a decoction, it is a complex mixture of various herbal ingredients. Its therapeutic effects are being studied in clinical trials.

Beyond the preview

Go deeper on Yixiao Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yixiao Decoction.

Explore the full profile